Hard to know what the market will make of it. Such a thinly traded stock.
My personal opinion:
Brazil growth: at face value Very Good. It's hard to get a foothold in new markets, seems like they may be developing some traction.
Europe: Good, given currency headwinds
Australia: Good
North America: Concerning. Described as an opportunity but sounds like they have their hands full.
Transition from Amalgam to growth products: Good
Doesn't appear to be a demanding valuation but worth keeping an eye on whether they're facing margin squeeze in the transition, especially if the North American business comes under further pressure.
The optimist in me thinks there's room for upside if things go right but there are risks as well.
I picked up a few more when others were tax loss selling in late June but I'm not strongly convicted either way.
Do your own research before investing.
- Forums
- ASX - By Stock
- SDI
- Ann: Media Release December 31 2016 Results
Ann: Media Release December 31 2016 Results, page-85
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SDI (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.06 |
Change
0.025(2.43%) |
Mkt cap ! $111.1M |
Open | High | Low | Value | Volume |
$1.04 | $1.06 | $1.04 | $68.79K | 65.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 93344 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.06 | 450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3840 | 0.790 |
1 | 5000 | 0.720 |
2 | 4500 | 0.700 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 3861 | 2 |
0.910 | 5000 | 1 |
0.920 | 10000 | 1 |
0.990 | 9810 | 2 |
0.000 | 0 | 0 |
Last trade - 15.58pm 25/11/2024 (20 minute delay) ? |
Featured News
SDI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online